Table: Oncolys Biopharma - Q1 parent results

Oncolys Biopharma

10/05/2019 07:01

May 10 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2019        Mar 31, 2018     Dec 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            48 mln              33 mln                     
                 (+42.8 pct)        (+120.2 pct)                  
  Operating     loss 364 mln        loss 302 mln                  
  Recurring     loss 359 mln        loss 310 mln                  
  Net           loss 360 mln        loss 311 mln                  
  EPS          loss 26.91 yen      loss 28.09 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T